4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells

Clinical and Experimental Immunology

Volumn 140, Issue 1, 2005, Pages 46-53

  Proulx, L I ^a   Gaudreault, M ^a   Turmel, V ^a   Augusto, L A ^a   Castonguay, A ^b   Bissonnette, Élyse Y ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

hydroxylation; Chemokines; Cytokines; Human lung epithelial cells

Indexed keywords

2 BUTANONE; 4 (ACETOXYMETHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; AUTACOID; CARCINOGEN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETOXYMETHYL N METHYLNITROSAMINE; NITROSAMINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TOBACCO SMOKE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALPHA METHYLENEHYDROXYLATION; ALPHA METHYLHYDROXYLATION; ARTICLE; BRONCHUS MUCOSA; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYDROXYLATION; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG CARCINOGENESIS; METABOLITE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SUPERNATANT; SYNOVITIS;

BRONCHI; CARCINOGENS; CELL LINE; CHEMOKINE CCL2; CYTOKINES; DIMETHYLNITROSAMINE; DINOPROSTONE; EPITHELIAL CELLS; HUMANS; HYDROXYLATION; INTERLEUKIN-6; INTERLEUKIN-8; NITROSAMINES; PULMONARY ALVEOLI; PYRIDINES;

EID: 16244371740     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02739.x     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. Cigarette smoking-attributable mortality and years of potential life lost - United States, 1990. JAMA 1993; 270:1408-13.
2. Monso E, Rosell A, Bonet G et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 1999; 13:338-42.
3. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91:1194-210.
4. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003; 54:113-29.
5. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998; 11:559-603.
6. Hecht SS. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol 1996; 26:163-81.
7. Smith TJ, Stoner GD, Yang CS. Activation of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone (NNK) in human lung microsomes by cytochrome P450, lipoxygenase and hydroperoxides. Cancer Res 1995; 55:5566-73.
8. Rioux N, Castonguay A. Induction of COX expression by a tobacco carcinogen: implication of lung cancer chemoprevention. Inflamm Res 1999; 48:S136-7.
9. Floreani AA, Rennard SI. The role of cigarette smoke in the pathogenesis of asthma as a trigger for acute symptoms. Curr Opin Pulm Med 1999; 5:38-46.
10. Takizawa H, Tanaka M, Takami K et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. Am J Physiol Lung Cell Mol Physiol 2000; 278:L906-13.
11. Wang H, Liu X, Umino T et al. Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol 2001; 25:772-9.
12. Polito AJ, Proud D. Epithelial cells as regulators of airway inflammation. J Allergy Clin Immunol 1998; 102:714-18.
13. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2000; 23:530-6.
14. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 155:1770-6.
15. Masubuchi T, Koyama S, Sato E et al. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Pathol 1998; 153:1903-12.
16. Hellermann GR, Nagy SB, Kong X, Lockey RF, Mohapatra SS. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 2002; 3:22.
17. Li XY, Rahman I, Donaldson K, MacNee W. Mechanisms of cigarette smoke induced increased airspace permeability. Thorax 1996; 51:465-71.
18. Hoshino Y, Mio T, Nagai S, Miki H, Ito I, Izumi T. Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol 2001; 281:L509-16.
19. Cloutier JF, Castonguay A. Modulation of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone-induced DNA repair by various inhibitors of DNA synthesis. Chem Biol Interact 1998; 110:7-25.
20. Therriault MJ, Proulx LI, Castonguay A, Bissonnette EY. Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages. Clin Exp Immunol 2003; 132:232-8.
21. Proulx LI, Castonguay A, Bissonnette EY. Cytokine production by alveolar macrophages is down regulated by the α-methylhydroxylation pathway of 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 2004; 25:997-1003.
22. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994; 56:559-64.
23. Froget S, Barthelemy E, Guillot F et al. Wound healing mediator production by human dermal fibroblasts grown within a collagen-GAG matrix for skin repair in humans. Eur Cytokine Netw 2003; 14:60-4.
24. Rusznak C, Sapsford RJ, Devalia JL et al. Interaction of cigarette smoke and house dust mite allergens on inflammatory mediator release from primary cultures of human bronchial epithelial cells. Clin Exp Allergy 2001; 31:226-38.
25. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 2004; 30:500-9.
26. Fischer S, Castonguay A, Kaiserman K, Spiegelhalder B, Preussmann R. Tobacco-specific nitrosamines in Canadian cigarettes. J Cancer Res Clin Oncol 1990; 116:563-8.
27. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9:1989-94.
28. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994; 150:696-703.
29. Soliman DM, Twigg HL 3rd. Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol 1992; 263:L471-8.
30. Luger TA, Krutmann J, Kirnbauer R et al. IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol 1989; 143:1206-9.
31. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem 1991; 266:9912-18.
32. Rollins BJ. Chemokines. Blood 1997; 90:909-28.
33. 2. Trends Immunol 2004; 25:40-6.
34. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23:144-50.
35. 2 production. J Oral Pathol Med 2001; 30:41-7.
36. Schrader E, Hirsch-Ernst KI, Scholz E, Kahl GF, Foth H. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells. Drug Metab Dispos 2000; 28:180-5.
37. West KA, Brognard J, Clark AS et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111:81-90.